Philadelphia, Nov. 24, 2010 –Thirteen new research projects on the public health impacts of laws and regulations on issues such as lead exposure, vaccinations, emergency preparedness, and the structure of state health agencies were funded today by the Robert Wood Johnson Foundation’s (RWJF) Public Health Law Research (PHLR) program.
TODAY, THE Centers for Disease Control and Prevention will launch a campaign to stop the overuse of antibiotics, which are fast becoming useless in the war against resistant infections.
The CDC is right on target. We cannot afford to simply wait for new antibiotics to solve this crisis. It takes years to develop new drugs and meanwhile resistant micro-organisms like the one carrying the NDM-1 gene are spreading fast.
An analysis commissioned by Public Health Law Research has found that laws aimed at spurring development of new drugs have also led to unintended public health problems.
Alex C. Wagenaar, associate director at PHLR, and Mildred M. Maldonado-Molina recently published an article in Alcoholism: Clinical and Experimental Research.
They write that more than "a hundred studies have established the effects of beverage alcohol taxes and prices on sales and drinking behaviors. Yet, relatively few studies have examined effects of alcohol taxes on alcohol-related mortality. We evaluated effects of multiple changes in alcohol tax rates in the state of Florida from 1969 to 2004 on disease (not injury) mortality."
This month's Robert Wood Johnson Foundation Clinical Scholars Health Policy Podcast guest is Aaron Kesselheim, MD, JD, MPH, a patent attorney, general internist and health services researcher from Harvard Medical School, and also a member of the PHLR National Advisory Commitee.
Wendy Wagner, from the Center for Global Energy, International Arbitration, and Environmental Law at the University of Texas School of Law, explores perceptions and perversity of computational modeling in making public health policy.
Should the government produce information on, say, climate, employment rates, or drug safety? If so, should it make that information freely available? Or, should it charge for access or perhaps allow access only for certain uses? Indeed, should the government bar private individuals who gather data from making those data freely available? Or, should they be taxed when they make data freely available?
Public Health Law Research has released its fifth call for proposals on studies that focus on the effects of laws and policies on public health.
The new call for proposals is available online: www.rwjf.org/cfp/phlr5
The deadline for submitting proposals is July 24, 2013 at 3 p.m. ET.
As much as $1 million is available in this round of funding for short-term studies. Studies up to 18 months long will be funded at up to $150,000 each.